-
Mashup Score: 1
In “Origin: A Genetic History of the Americas,” Jennifer Raff combines archaeology, genetics, linguistics and more to argue against a longstanding theory.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Exploring Bias in Scientific Peer Review: An ASCO Initiative - 2 year(s) ago
PURPOSE: To investigate implicit bias (IB) in the peer review process across ASCO and Conquer Cancer Foundation and to propose potential mitigation strategies. MATERIALS AND METHODS: We, ASCO Working Group on Implicit Bias, selected four data sources: (1) literature search [(a) defining IB in peer review, (b) evidence of IB in peer review, and (c) strategies to mitigate IB]; (2) created and…
Source: JCO Oncology PracticeCategories: Hem/Oncs, Latest HeadlinesTweet-
https://t.co/fHnapz8xU1
-
-
Mashup Score: 0A Review of Risk in Cervical Cancer: An Analysis of the ASCCP Guidelines & NCI Risk MatrixBD_HPV_Brief MIF 3147-03 - 2 year(s) ago
From the approval of an HPV test with extended genotyping to the role of the NCI Risk Matrix, what do we need to know about the ASCCP Risk-Based Management Consensus Guidelines, and how will these updates impact the treatment pathways we recommend to our patients being screening for cervical cancer? Dr. Jeffery Andrews shares guideline recommendations and updates.
Source: reachmd.comCategories: Hem/Oncs, Latest HeadlinesTweet-
The NCI Risk Matrix Calculator is primarily based on the KPNC Data. The BD Onclarity, New Mexico HPV-Pap Repository, CDC’s Nat”l Breast/Cervix Early Detect Prog, Athena, and the Miss. Strides Trial. Mixed infections prioritized 16 then 18 then 33, etc. https://t.co/oOkzNZIjep
-
-
Mashup Score: 02022 ESMO Florida | Total Health Conferencing - 2 year(s) ago
Total Health Conferencing’s 2022 ESMO Review will be a condensed review of the global meeting and will give healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care.
Source: Total HealthCategories: Hem/Oncs, Latest HeadlinesTweet-
I’m presenting at the first-ever ESMO U.S. To be held in Fort Lauderdale on October 8-9, 2022! Attend in-person or virtually and hear key insights from the #ESMO22 Congress and earn 7.75 CME/CE credits and MOC points. Register Free: https://t.co/qaLoQHvyqY
-
-
Mashup Score: 3Human papillomavirus-independent cervical cancer - 2 year(s) ago
Cervical cancer is the fourth most frequent cancer in women worldwide, representing nearly 8% of all female cancer deaths every year. The majority of cases of cervical cancer are caused by human papillomavirus (HPV); however, up to 5% of tumors are not associated with HPV-persistent infection and, moreover, the new WHO Female Genital Tumors classification subdivided cervical squamous and…
Categories: Hem/Oncs, Latest HeadlinesTweet-
#article by @RParejaGineOnco et al HPVI have: p53+, low CDKI (p16, p14, and p27), altered PTEN, p53, KRAS, CTNNB1, ARID1A, and ARID5B; associated with lymph node+ in early stages, more distant metastasis, and worse onc outcomes #IGCS https://t.co/7qTGWmkOU5
-
-
Mashup Score: 0
Grains have historically represented a major component of human diets and were predominantly consumed in whole form until the first half of the 19th c…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Could the quality of grains affect the #microbiome and #metabolic homeostasis. How do we balance shelf-life, and #foodInsecurity with #nutrition #cancerPrevention and #tertiaryPrevention @ACLifeMed @ASPODisparities @ASPrevOnc https://t.co/NI0bcbJOu8
-
-
Mashup Score: 30Gynecologic Cancer - 2 year(s) ago
Gynecologic Cancer
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ASCO: Check out our rapid guideline update on #PARPinhibitors in the management of #OvarianCancer: https://t.co/yaH3jQMWO8 #gyncsm http…
-
-
Mashup Score: 0e-Posters - ESMO Congress 2022 - 2 year(s) ago
BackgroundNiraparib (nir) has shown PFS benefit as a first-line (1L) maintenance therapy (MT) in the PRIMA primary analysis (data cut 17 May 2019) in all subgroups regardless of biomarker status. These results were the basis for approval of nir as MT after response to 1L platinum-based chemo (CT). Here we report updated long-term efficacy and safety in the PRIMA study.MethodsThis double-blind,…
Source: cslide.ctimeetingtech.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Looking forward to seeing new data from e-Posters - ESMO Congress 2022 #GYNCSM #GYNCANCER #studyresults https://t.co/j5RpHP4q3D
-
-
Mashup Score: 0Some thoughts about surgery in ovarian cancer 2021 - 2 year(s) ago
This lecture discusses critical aspects of surgery in ovarian cancer. Video 1 ![Figure 1][1] Figure 1 Prof. Dr. Dr. h.c. Andreas du Bois. (1) Access to optimal state-of-the art quality of care: Not all patients have access to high-quality centers. The European Society of
Categories: Latest Headlines, Oncologists2Tweet-
Great video by @AndreasDuBois 2021 | International Journal of Gynecologic Cancer @IGCSociety @IJGConline #ovariancancer #optimalCRS #ProperPatientSelection https://t.co/QvvbVheeV3
-
-
Mashup Score: 1Fiber in diet linked to cancer immunotherapy response - 2 year(s) ago
People who ate a high-fiber diet and didn’t use over-the-counter probiotic supplements lived the longest after immunotherapy for melanoma.
Categories: Hem/Oncs, Latest HeadlinesTweet-
Fiber in diet linked to cancer immunotherapy response | National Institutes of Health (NIH). Great work by @JenWargoMD and colleagues. Excited to start @AHFoundationCFL @AdventHealthMD @DrWinkfield https://t.co/1RY27vBznd
-
A more recent discovery indicates that humans hunted mammoth in Florida 14,500 years ago. Did the First Americans Arrive via Land Bridge? From Asia to Alaska and Americas Interesting article The New York Times #DeColonializeScience https://t.co/YrqxW5mjMt